C101 IPF: CLINICAL STUDIES, THERAPEUTICS, AND MORE II: Bronchoalveolar Lavage Fluid Cytokine Profiles In Idiopathic Pulmonary Fibrosis Patients May Define Distinct Prognostic Groups

While some IPF patients achieve stabilization on treatment, there is a group of patients with unevitable lung functions decline despite treatment. All patients were treated with antifibrotics (pirfenidon or nintedanib according to reimbursement rules of health care provider) and LF were recorded 6 month after IPF diagnosis.